Clinical trials sponsored by Memorial Sloan Kettering Cancer Center

Phase breakdown

Conditions studied

Recruiting trials led by Memorial Sloan Kettering Cancer Center

• A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
  NCT05438511 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Registry for People With Lung Cancer
  NCT06424327 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 18 locations
• A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
  NCT05053230 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
  NCT06347705 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 7 locations
• A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
  NCT05562791 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
  NCT06678269 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
  NCT06057935 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 13 locations
• A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
  NCT07220967 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 7 locations
• A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer
  NCT07335796 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
  NCT03334708 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 13 locations
• A Study of Blood Pressure Control During Cancer Treatment
  NCT06023576 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 7 locations
• A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
  NCT07227636 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors
  NCT05574127 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · 1 location
• A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
  NCT06736613 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
  NCT07768436 · Phase: Phase 2 · Ages: 70 Years and older · Sex: All (male and female) · 7 locations
• A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
  NCT07671339 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
  NCT06099769 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
  NCT06594991 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• A Study of Hospital-at-Home for People Receiving Tarlatamab
  NCT06957314 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
  NCT05736419 · Phase: Phase 2 · Ages: 2 Years to 50 Years · Sex: All (male and female) · 6 locations
• A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
  NCT05607095 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
  NCT06110793 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
  NCT07635238 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 7 locations
• A Study of Lung Cancer Risk
  NCT07701733 · Phase: Not specified · Ages: 40 Years to 74 Years · Sex: All (male and female) · 7 locations
• A Study of Luspatercept in People With Anemia
  NCT07725497 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
  NCT05859074 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
  NCT07612046 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
  NCT07225309 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study of Mental Health Care in People With Cancer
  NCT06037954 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · 3 locations
• A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
  NCT06623396 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
  NCT05130801 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Female · 2 locations
• A Study of Multiparametric Ultrasound Imaging Methods
  NCT07270237 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
  NCT04683679 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 7 locations
• A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
  NCT05837767 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 14 locations
• A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
  NCT06637462 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• A Study of Romosozumab in People With Breast Cancer and Osteoporosis
  NCT07776613 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 7 locations
• A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
  NCT06130280 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Sotorasib in People With Non-Small Cell Lung Cancer
  NCT06582771 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Tarlatamab for People With Prostate Cancer
  NCT07111507 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 10 locations
• A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
  NCT07619339 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
  NCT05672524 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
  NCT06807632 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of ZEN003694 in People With Squamous Cell Lung Cancer
  NCT05607108 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of a New PET Scanner in People With Cancer
  NCT07690917 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 14 locations
• A Study of a Side Effects and Resource Navigation Program for People With Cancer
  NCT07646847 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• A Study of a Weight Loss Intervention in People With Endometrial Cancer
  NCT06751589 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Female · 7 locations
• A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers
  NCT06305741 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · 7 locations
• A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
  NCT07483307 · Phase: Phase 2 · Ages: 50 Years and older · Sex: Female · 7 locations
• A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer
  NCT05910294 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 7 locations
• Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
  NCT04991025 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
  NCT00582621 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 6 locations
• Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
  NCT05384496 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
  NCT04668872 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
  NCT04812912 · Phase: Not specified · Ages: 18 Years to 50 Years · Sex: All (male and female) · 7 locations
• Collection of Information to Better Understand Young Onset Colorectal Cancer
  NCT04489238 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
  NCT07548164 · Phase: Phase 3 · Ages: No age limits stated · Sex: Male · 8 locations
• DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
  NCT07225088 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 100 Years · Sex: All (male and female) · 7 locations
• Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
  NCT04751435 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
  NCT06728579 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 9 locations
• Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
  NCT04458532 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 80 Years · Sex: Female · 2 locations
• Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
  NCT05424029 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
  NCT07144800 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
  NCT02772367 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
  NCT02706561 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years and older · Sex: Male · 1 location
• Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
  NCT06305728 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
  NCT02393703 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
  NCT03808337 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 24 locations
• Lymphedema Surveillance Study
  NCT02743858 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 7 locations
• MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
  NCT06954337 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Neurocutaneous Melanocytosis Registry
  NCT04548817 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
  NCT05590949 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 7 locations
• Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
  NCT04410796 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations
• Radiation Therapy Approaches for People With Prostate Cancer
  NCT07751159 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 7 locations
• Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes
  NCT03396341 · Phase: Not specified · Ages: 25 Years and older · Sex: Female · 7 locations
• Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
  NCT06129903 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
  NCT04084730 · Phase: Phase 2 · Ages: 45 Years and older · Sex: Female · 9 locations
• Study of Aerobic Training for People Receiving Treatment for Breast Cancer
  NCT05716893 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 7 locations
• Study of How People Make Decisions About Prostate Cancer Risk
  NCT07197723 · Phase: Not specified · Ages: 45 Years to 70 Years · Sex: Male · 1 location
• Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
  NCT04165772 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
  NCT03572374 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: Female · 9 locations
• The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
  NCT04167969 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 2 locations
• Tislelizumab in People With Colorectal Cancer
  NCT06529523 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
  NCT07218601 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
  NCT00588185 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: Male · 7 locations

Common questions

How many trials is Memorial Sloan Kettering Cancer Center recruiting for?

Memorial Sloan Kettering Cancer Center is the lead sponsor of 84 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.